Spectrum Pharmaceuticals Announces FDA Approval of NDA for EVOMELA (melphalan) for Injection for use in two indications
March 11, 2016 at 07:14 AM EST
On March 10, 2016, Spectrum Pharmaceuticals, Inc. (the "Company") received notification from the U.S. Food and Drug Administration of ...
